v3.25.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2025
Stockholders' Equity [Abstract]  
Schedule of Stock Option and Restricted Stock Unit Activity

A summary of the Company’s stock option and restricted stock unit activity under its plans is as follows:

 

  

Number of
Shares
Subject to
Outstanding
Stock Options

   Weighted
Average
Exercise
Price per
Share
  

Number of

Outstanding

Restricted Stock

Units

  

Weighted

Average Grant

Date Fair

Value per

Unit

 
Outstanding at December 31, 2024   11,322   $20.79    20,224   $99.58 
Granted   
    
    77,150   $1.85 
Released   
    
    (461)  $202.88 
Forfeited   (625)  $11.35    
    
 
Outstanding at March 31, 2025   10,697   $21.34    96,913   $19.27 
Schedule of Stock-Based Compensation Expense Recognized

The following table sets forth stock-based compensation expense recognized for the three months ended March 31, 2024 and 2023:

 

   Three months ended
March 31,
 
   2025   2024 
Research and development  $349   $367 
Sales and marketing   37    43 
General, and administrative   486    608 
Total stock-based compensation expense  $872   $1,018